Cardiac Resynchronization Therapy
Cardiac resynchronization therapy involves the placement of an implantable biventricular pacing device with three leads (right atrial, right ventricular and left ventricular) that synchronize ventricular contractions.
Physicians at the Massachusetts General Hospital Corrigan Minehan Heart Center offer cardiac resynchronization therapy (CRT) or CRT-D (CRT with defibrillator therapy) as an innovative therapeutic option for patients with refractory heart failure. Many patients with heart failure experience an abnormality in the pumping of the heart’s ventricles and need special treatment to synchronize the pumping.
Cardiac resynchronization therapy involves the placement of an implantable biventricular pacing device with three leads (right atrial, right ventricular and left ventricular) that synchronize ventricular contractions. This greatly improves the pumping efficiency of the heart.
Cardiac resynchronization therapy is associated with:
- Improved quality of life
- Increased exercise capacity
- Reduction in hospitalization for heart failure
- Reduction in mortality rates
Cardiac resynchronization therapy has gained widespread acceptance as a safe, effective therapy for qualifying patients with advanced heart failure.
New wireless technology allows Heart Center clinicians to keep tabs on heart failure patients wherever they are
Jagmeet Singh, MD, Director of the Cardiac Resynchronization Therapy Program at the Massachusetts General Hospital Heart Center, discusses his team’s recent study about multidisciplinary care (MC) versus conventional care (CC) in CRT (cardiac resynchronization therapy) patients.
Learn how researchers at the Corrigan Minehan Heart Center are finding new treatments that advance care for heart disease.
View the Corrigan Minehan Heart Center’s latest awards for outstanding patient care and groundbreaking research.
U.S. News & World Report ranks the Mass General Corrigan Minehan Heart Center fifth among U.S. hospitals.